Wilson Sonsini Goodrich & Rosati advised Lilly Asia Ventures on the deal.Regor Therapeutics, a clinical-stage biotechnology company dedicated to the discovery of innovative medicines to treat…
Regor Therapeutics’ $90 Million Series B Financing


Wilson Sonsini Goodrich & Rosati advised Lilly Asia Ventures on the deal.Regor Therapeutics, a clinical-stage biotechnology company dedicated to the discovery of innovative medicines to treat…
…